Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (291-300 of 414) with videos related to

Pageof 42
Sort By:
Arthritis Care & Research|August 29, 2015
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension StudyD J Wallace, K Hobbs, M E B Clowse, et al.
Journal of Translational Autoimmunity|January 10, 2022
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosusRebecca A Wood, Lauren Guthridge, Emma Thurmond, et al.
Arthritis and Rheumatism|August 14, 1999
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndromeN Hirose, R Williams, A R Alberts, et al.
The New England Journal of Medicine|October 15, 2025
A Phase 3 Trial of Telitacicept for Systemic Lupus ErythematosusRonald F van Vollenhoven, Li Wang, Joan T Merrill, et al.
Rheumatology (Oxford, England)|March 17, 2009
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritisPeter M Izmirly, Laura Barisoni, Jill P Buyon, et al.
Seminars in Arthritis and Rheumatism|April 7, 2012
Disease-specific patient reported outcome tools for systemic lupus erythematosusMeenakshi Jolly, A Simon Pickard, Joel A Block, et al.
Annals of the Rheumatic Diseases|April 28, 2022
Biological impact of iberdomide in patients with active systemic lupus erythematosusPeter E Lipsky, Ronald van Vollenhoven, Thomas Dörner, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 25, 2024
Optic Disc Edema Is an Under-Recognized Feature of Birdshot ChorioretinitisSharon Sabapathypillai, Victoria J Miller, Akbar Shakoor, et al.
Annals of the Rheumatic Diseases|November 27, 2009
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestryXana Kim-Howard, Amit K Maiti, Juan-Manuel Anaya, et al.
Nature Genetics|January 22, 2008
A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosusSwapan K Nath, Shizhong Han, Xana Kim-Howard, et al.
Pageof 42

Showing results (291-300 of 414) with videos related to

Sort By:
Pageof 42
Arthritis Care & Research|August 29, 2015
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension StudyD J Wallace, K Hobbs, M E B Clowse, et al.
Journal of Translational Autoimmunity|January 10, 2022
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosusRebecca A Wood, Lauren Guthridge, Emma Thurmond, et al.
Arthritis and Rheumatism|August 14, 1999
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndromeN Hirose, R Williams, A R Alberts, et al.
The New England Journal of Medicine|October 15, 2025
A Phase 3 Trial of Telitacicept for Systemic Lupus ErythematosusRonald F van Vollenhoven, Li Wang, Joan T Merrill, et al.
Rheumatology (Oxford, England)|March 17, 2009
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritisPeter M Izmirly, Laura Barisoni, Jill P Buyon, et al.
Seminars in Arthritis and Rheumatism|April 7, 2012
Disease-specific patient reported outcome tools for systemic lupus erythematosusMeenakshi Jolly, A Simon Pickard, Joel A Block, et al.
Annals of the Rheumatic Diseases|April 28, 2022
Biological impact of iberdomide in patients with active systemic lupus erythematosusPeter E Lipsky, Ronald van Vollenhoven, Thomas Dörner, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 25, 2024
Optic Disc Edema Is an Under-Recognized Feature of Birdshot ChorioretinitisSharon Sabapathypillai, Victoria J Miller, Akbar Shakoor, et al.
Annals of the Rheumatic Diseases|November 27, 2009
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestryXana Kim-Howard, Amit K Maiti, Juan-Manuel Anaya, et al.
Nature Genetics|January 22, 2008
A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosusSwapan K Nath, Shizhong Han, Xana Kim-Howard, et al.
Pageof 42